We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
COVID‐19‐associated mucormycosis involving the maxilla.
- Authors
Hasheminasab, Mahboube; Karizmeh, Mojtaba Salehi; Sharifi, Reza; Beshkar, Majid; Matloubi, Narges; Asadi, Amir Ali; Nazar, Elham
- Abstract
It is important to increase the awareness and knowledge of head and neck surgeons about the recent surge of craniofacial mucormycosis in COVID‐19 patients because early diagnosis and appropriate treatment are essential to improve the outcomes. Here, we describe clinical features, treatment protocols, and outcomes of treatment in eight patients with COVID‐19‐associated mucormycosis in the maxilla. Consistent with the findings of previous studies, our experience in the management of these eight patients shows that early administration of amphotericin B and prompt aggressive surgery are essential for optimal control of the disease.
- Subjects
MAXILLA; MUCORMYCOSIS; AMPHOTERICIN B; HEAD &; neck cancer; COVID-19; MEDICAL protocols; TREATMENT effectiveness
- Publication
Clinical Case Reports, 2022, Vol 10, Issue 8, p1
- ISSN
2050-0904
- Publication type
Case Study
- DOI
10.1002/ccr3.6165